Position history for VANGUARD GROUP INC's holdings in AVIDITY BIOSCIENCES INC
VANGUARD GROUP INC holds 13.6M shares of RNA (AVIDITY BIOSCIENCES INC), worth $984.5M as of 2025-Q4. The position was increased (++3.3% shares). RNA represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$984.5M
Current Shares
13.6M
Total Value Change
+$560.7M
Total Shares Change
+4.4M
Other major holders of RNA: FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS, JANUS HENDERSON GROUP PLC
Increased |
| 13.6M |
+3.3% |
| $984.5M |
| 0.0% |
| $72.15 |
33 |
| 2025-Q3 | Increased | 13.2M | +42.9% | $576M | 0.0% | $42.63 | 42 |
| 2025-Q2 | Increased | 9.2M | +0.1% | $262.7M | 0.0% | $29.03 | 31 |
| 2025-Q1 | Decreased | 9.2M | -2.0% | $272.9M | 0.0% | $31.60 | 0 |
| 2024-Q4 | Increased | 9.4M | +2.2% | $274.3M | 0.0% | $29.18 | 31 |
| 2024-Q3 | New | 9.2M | - | $423.8M | 0.0% | $42.33 | 43 |